Skip to main content

Table 3 Assessment of toxicity (case, %)

From: First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer

Toxicity

Grade(WHO)

 

0

I

II

III

IV

Rash

21(46.7)

19(42.2)

4(8.9)

1(2.2)

0(0)

Pruritus

35(77.8)

10(22.2)

0

0

0

Dry skin

33(73.3)

11(24.4)

1(2.2)

0

0

Diarrhea

30(66.7)

13(28.9)

2(4.4)

0

0

Oral ulcer

43(95.6)

2(4.4)

0

0

0

Nausea/vomit

37(82.2)

8(17.8)

0

0

0

Hepatic toxicity

42(93.3)

1(2.2)

2(4.4)

0

0

Interstitial lung Disease(ILD)

45(100.0)

0

0

0

0